Loading organizations...
§ Private Profile · Austin, TX, USA
A healthcare-enabling research organization accelerating clinical trials for diverse patients and product development.
Based in Austin, Texas, Elligo Health Research is a healthcare research organization that accelerates clinical trials by connecting pharmaceutical and biotechnology companies directly with diverse patient populations. The company utilizes electronic health record data and proprietary technology to integrate clinical research into standard medical care across a network of over 115 hospitals and 200 healthcare sites. Operating with approximately 400 employees, the business generates an estimated $84.5 million in annual revenue by providing infrastructure and personnel to clinics while charging sponsors for trial acceleration services. Backed by investors including Morgan Stanley Expansion Capital, the organization previously raised $135 million in Series E funding to finance the strategic acquisition of clinical research firm ClinEdge. Currently led by Chief Executive Officer Barry Simms, Elligo Health Research was founded in 2016 by John Potthoff and Chad Moore.
Elligo Health Research has raised $211.0M across 4 funding rounds.
Elligo Health Research has raised $211.0M in total across 4 funding rounds.
Elligo Health Research has raised $211.0M in total across 4 funding rounds.
Elligo Health Research's investors include Horizon Technology Finance, Charles Chon, Melissa Daniels, Cerner, Hatteras Venture Partners, Norwest Venture Partners, Piper Sandler Merchant Banking, Shumway Capital, Syneos Health, Thomas Schnettler, John Crumpler, Excelerate Health Ventures.
Elligo Health Research has raised $211.0M across 4 funding rounds. Most recently, it raised $40.0M Debt in October 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 2, 2023 | $40M Debt Financing | Horizon Technology Finance | — | Announced |
| Sep 24, 2021 | $135M Series E | Charles Chon, Melissa Daniels | Cerner, Hatteras Venture Partners, Norwest Venture Partners, Piper Sandler Merchant Banking, Shumway Capital, Syneos Health | Announced |
| May 7, 2019 | $20M Series C | Thomas Schnettler | John Crumpler | Announced |
| Mar 20, 2018 | $16M Series B | John Crumpler | Excelerate Health Ventures, FS Healthcare, Shumway Capital | Announced |